1185887-51-7

AB-CHMINACA is an indazole-based synthetic cannabinoid (CB) that is structurally related to AB-FUBINACA , a high affinity ligand of the central CB₁ receptor (K_i = 0.9 nM). AB-CHMINACA metabolite M2 is a metabolite of AB-CHMINACA that can be detected in the urine. The physiological and toxicological properties of this compound are not known. This product is intended for forensic and research applications.

AB-CHMINACA is an indazole-based synthetic cannabinoid (CB) that is structurally related to AB-FUBINACA , a high affinity ligand of the central CB1 receptor (Ki = 0.9 nM). AB-CHMINACA metabolite M2 is a metabolite of AB-CHMINACA that can be detected in the urine. The physiological and toxicological properties of this compound are not known. This product is intended for forensic and research applications.[Cayman Chemical]

[1] N. UCHIYAMA. New cannabimimetic indazole derivatives, N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (AB-PINACA) and N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (AB-FUBINACA) identified as designer drugs in illegal products[J]. Forensic Toxicology, 2012, 31 1: 93-100. DOI: 10.1007/s11419-012-0171-4
[2] KIKELJ D. From Indazole Derivatives[C]. 1900: 0. DOI: 10.1055/sos-sd-016-00861
[3] AMIN WURITA. Identification and quantification of metabolites of AB-CHMINACA in a urine specimen of an abuser[J]. Legal Medicine, 2016, 19: Pages 113-118. DOI: 10.1016/j.legalmed.2015.07.011
[4] JOSEPH A TYNDALL. An outbreak of acute delirium from exposure to the synthetic cannabinoid AB-CHMINACA.[J]. Cliometrica, 2015, 3 1: 950-956. DOI: 10.3109/15563650.2015.1100306